Only patients who were homozygous for the 4G allele were at risk for MI with the greatest pro-insulin values, implying that PAI-1 genotype may alter the vascular risk associated with hyperinsulinemia [19]. The gene discussed is SERPINE1; the disease is hyperinsulinism.